The Discounted Cash Flow (DCF) valuation of Shield Therapeutics PLC (STX.L) is (147.58) GBP. With the latest stock price at 2.75 GBP, the upside of Shield Therapeutics PLC based on DCF is -5466.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 50.5% | 29.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,464.25) - (77.21) | (147.58) |
| Upside | -53345.6% - -2907.6% | -5466.4% |